ZA904715B - Novel acetylcholinesterase inhibitors - Google Patents

Novel acetylcholinesterase inhibitors

Info

Publication number
ZA904715B
ZA904715B ZA904715A ZA904715A ZA904715B ZA 904715 B ZA904715 B ZA 904715B ZA 904715 A ZA904715 A ZA 904715A ZA 904715 A ZA904715 A ZA 904715A ZA 904715 B ZA904715 B ZA 904715B
Authority
ZA
South Africa
Prior art keywords
acetylcholinesterase inhibitors
novel acetylcholinesterase
novel
inhibitors
acetylcholinesterase
Prior art date
Application number
ZA904715A
Other languages
English (en)
Inventor
Daniel Schirlin
Schirlin Daniel
Jean-Noel Collard
Collard Jean-Noel
Jean-Marie Hornsperger
Hornsperger Jean-Marie
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA904715B publication Critical patent/ZA904715B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
ZA904715A 1989-06-22 1990-06-18 Novel acetylcholinesterase inhibitors ZA904715B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89401775A EP0403713A1 (en) 1989-06-22 1989-06-22 Novel acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
ZA904715B true ZA904715B (en) 1991-04-24

Family

ID=8202963

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904715A ZA904715B (en) 1989-06-22 1990-06-18 Novel acetylcholinesterase inhibitors

Country Status (19)

Country Link
EP (2) EP0403713A1 (ko)
JP (1) JP2879951B2 (ko)
KR (1) KR0139529B1 (ko)
CN (1) CN1027759C (ko)
AR (1) AR247214A1 (ko)
AT (1) ATE119535T1 (ko)
AU (1) AU626428B2 (ko)
CA (1) CA2019231C (ko)
DE (1) DE69017543T2 (ko)
DK (1) DK0409676T3 (ko)
ES (1) ES2072406T3 (ko)
FI (1) FI97619C (ko)
HU (1) HU210569B (ko)
IE (1) IE66155B1 (ko)
IL (1) IL94779A (ko)
NO (1) NO178374C (ko)
NZ (1) NZ234136A (ko)
PT (1) PT94449B (ko)
ZA (1) ZA904715B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0611769A1 (en) * 1993-02-16 1994-08-24 Merrell Dow Pharmaceuticals Inc. Silylated acetylcholinesterase inhibitors
US5523442A (en) * 1993-02-16 1996-06-04 Merrell Pharmaceuticals Inc. Silylated acetylcholinesterase inhibitors
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
US5554780A (en) * 1994-05-05 1996-09-10 Merrell Pharmaceuticals Inc. Process for the preparation of 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
US5486638A (en) * 1994-11-08 1996-01-23 Marion Merrell Dow Inc. Process for the preparation of 1-halo-3-trialkysilanyl-benzene derivatives
EP0749972A1 (en) 1995-06-21 1996-12-27 Merrell Pharmaceuticals Inc. A process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
CN1059702C (zh) * 1997-12-30 2000-12-20 中国科学院上海细胞生物学研究所 从哺乳类细胞中获得脑型乙酰胆碱酯酶的方法
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US6084117A (en) * 1999-11-22 2000-07-04 Albemarle Corporation Production of silated haloarenes by selective silylation of polyhaloarenes
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
MX362886B (es) 2012-12-13 2019-02-22 H Lundbeck As Composición sinérgica que comprende vortioxetina y donepezilo para incrementar los niveles de acetilcolina en el cerebro, y el uso de la misma en el tratamiento de una disfunción cognitiva.
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL25820A (en) * 1966-05-22 1971-02-25 Yissum Res Dev Co Silicon containing beta-hydroxy alpha-phenyl carboxylic acids,their amide and ester derivatives and intermediates for their preparation
US4835099A (en) * 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis

Also Published As

Publication number Publication date
HU210569B (en) 1995-05-29
DK0409676T3 (da) 1995-03-27
AU5758490A (en) 1991-01-03
FI903104A0 (fi) 1990-06-20
EP0409676A1 (en) 1991-01-23
HUT54695A (en) 1991-03-28
KR910000757A (ko) 1991-01-30
AU626428B2 (en) 1992-07-30
CA2019231A1 (en) 1990-12-22
CN1027759C (zh) 1995-03-01
NO902776L (no) 1990-12-27
IL94779A (en) 1996-09-12
JPH0338591A (ja) 1991-02-19
ATE119535T1 (de) 1995-03-15
JP2879951B2 (ja) 1999-04-05
NZ234136A (en) 1994-04-27
CN1048389A (zh) 1991-01-09
DE69017543T2 (de) 1995-07-06
EP0403713A1 (en) 1990-12-27
IE902252A1 (en) 1991-01-16
FI97619B (fi) 1996-10-15
NO902776D0 (no) 1990-06-21
HU903933D0 (en) 1990-11-28
CA2019231C (en) 2000-07-11
EP0409676B1 (en) 1995-03-08
IE66155B1 (en) 1995-12-13
IE902252L (en) 1990-12-22
PT94449A (pt) 1991-02-08
ES2072406T3 (es) 1995-07-16
FI97619C (fi) 1997-01-27
PT94449B (pt) 1997-02-28
KR0139529B1 (ko) 1998-07-01
DE69017543D1 (de) 1995-04-13
NO178374B (no) 1995-12-04
AR247214A1 (es) 1994-11-30
NO178374C (no) 1996-03-13

Similar Documents

Publication Publication Date Title
GB8908063D0 (en) Novel compounds
ZA904715B (en) Novel acetylcholinesterase inhibitors
HU906389D0 (en) New alpha-glycosidase inhibitors
GB8908638D0 (en) Novel compounds
ZA907422B (en) Further novel alkanophenones
ZA902279B (en) Novel alpha-glucosidase inhibitors
GB8905160D0 (en) Novel compounds
IL95679A0 (en) Novel alkanophenones
GB8905605D0 (en) Novel compounds
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
GB8909878D0 (en) Inhibitor
GB8901145D0 (en) Novel compounds
GB8901163D0 (en) Novel compounds
GB8905310D0 (en) Novel compounds
GB8900383D0 (en) Novel compounds
GB8901141D0 (en) Novel compounds
GB8906261D0 (en) Novel compounds
GB8903558D0 (en) Novel compounds
GB8902721D0 (en) Novel compounds
GB8906329D0 (en) Novel compounds
GB8906592D0 (en) Novel compounds
GB8904041D0 (en) Novel compounds
GB8907171D0 (en) Novel compounds
GB8907174D0 (en) Novel compounds
GB8907297D0 (en) Novel compounds